Literature DB >> 26408795

Microglia activation is associated with IFN-α induced depressive-like behavior.

Simone Wachholz1, Manuela Eßlinger2, Jennifer Plümper3, Marie-Pierre Manitz4, Georg Juckel5, Astrid Friebe6.   

Abstract

Inflammatory immune activation has been frequently associated with the development of major depression. This association was confirmed in patients receiving long-term treatment with pro-inflammatory interferon-α (IFN-α). Microglia, the resident immune cells in the brain, might serve as an important interface in this immune system-to-brain communication. The aim of the present study was to investigate the role of microglia in an IFN-α mouse model of immune-mediated depression. Male BALB/c mice were treated with daily injections of IFN-α for two weeks. Depressive-like behavior was analyzed in the forced swim and tail suspension test. Activation of microglia was measured by flow cytometry. Pro-inflammatory M1 type (MHC-II, CD40, CD54, CD80, CD86, CCR7), anti-inflammatory M2 type (CD206, CD200R), and maturation markers (CD11c, CCR7) were tested, as well as the chemokine receptor CCR2. IFN-α led to a significant increase in depressive-like behavior and expression of the pro-inflammatory surface markers MHC-II, CD86, and CD54, indicating M1 polarization. Because IFN-α-treated mice showed great individual variance in the behavioral response to IFN-α, they were further divided into vulnerable and non-vulnerable subgroups. Only IFN-α vulnerable mice (characterized by their development of depressive-like behavior in response to IFN-α) showed an increased expression of MHC-II and CD86, while CD54 was similarly enhanced in both subgroups. Thus, IFN-α-induced activation of microglia was specifically associated with depressive-like behavior.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD54; CD86; Depression; Depressive-like behavior; Interferon-alpha; MHC-II; Microglia

Mesh:

Substances:

Year:  2015        PMID: 26408795     DOI: 10.1016/j.bbi.2015.09.016

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  21 in total

Review 1.  The role of microglia in chronic pain and depression: innocent bystander or culprit?

Authors:  Nan Yin; Enshi Yan; Wenbin Duan; Changyuan Mao; Qin Fei; Chun Yang; Yimin Hu; Xiaolin Xu
Journal:  Psychopharmacology (Berl)       Date:  2021-02-05       Impact factor: 4.530

Review 2.  Modulators of microglial activation and polarization after intracerebral haemorrhage.

Authors:  Xi Lan; Xiaoning Han; Qian Li; Qing-Wu Yang; Jian Wang
Journal:  Nat Rev Neurol       Date:  2017-05-19       Impact factor: 42.937

3.  Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques.

Authors:  Ethan R Roy; Gabriel Chiu; Sanming Li; Nicholas E Propson; Rupa Kanchi; Baiping Wang; Cristian Coarfa; Hui Zheng; Wei Cao
Journal:  Immunity       Date:  2022-04-19       Impact factor: 43.474

Review 4.  Immunoneuropsychiatry - novel perspectives on brain disorders.

Authors:  Marion Leboyer; Frauke Zipp; Katrin Pape; Ryad Tamouza
Journal:  Nat Rev Neurol       Date:  2019-06       Impact factor: 42.937

5.  Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease.

Authors:  Ethan R Roy; Baiping Wang; Ying-Wooi Wan; Gabriel Chiu; Allysa Cole; Zhuoran Yin; Nicholas E Propson; Yin Xu; Joanna L Jankowsky; Zhandong Liu; Virginia M-Y Lee; John Q Trojanowski; Stephen D Ginsberg; Oleg Butovsky; Hui Zheng; Wei Cao
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

6.  B-cells are abnormal in psychosocial stress and regulate meningeal myeloid cell activation.

Authors:  Mary-Ellen Lynall; Stacey L Kigar; Michael L Lehmann; Allison E DePuyt; Zewen Kelvin Tuong; Samuel J Listwak; Abdel G Elkahloun; Edward T Bullmore; Miles Herkenham; Menna R Clatworthy
Journal:  Brain Behav Immun       Date:  2021-08-08       Impact factor: 19.227

Review 7.  The impact of systemic lupus erythematosus on women's sexual functioning: A systematic review and meta-analysis.

Authors:  Rulan Yin; Bin Xu; Lin Li; Ting Fu; Lijuan Zhang; Qiuxiang Zhang; Xia Li; Biyu Shen
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 8.  Microglia: An Interface between the Loss of Neuroplasticity and Depression.

Authors:  Gaurav Singhal; Bernhard T Baune
Journal:  Front Cell Neurosci       Date:  2017-09-08       Impact factor: 5.505

9.  Kososan, a Kampo medicine, prevents a social avoidance behavior and attenuates neuroinflammation in socially defeated mice.

Authors:  Naoki Ito; Eiji Hirose; Tatsuya Ishida; Atsushi Hori; Takayuki Nagai; Yoshinori Kobayashi; Hiroaki Kiyohara; Tetsuro Oikawa; Toshihiko Hanawa; Hiroshi Odaguchi
Journal:  J Neuroinflammation       Date:  2017-05-03       Impact factor: 8.322

Review 10.  Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System.

Authors:  Kim M A De Kleijn; Gerard J M Martens
Journal:  Int J Mol Sci       Date:  2020-06-13       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.